Isotretinoin

Product NDC
84386-010
11-digit product format
843860010
Labeler code
84386
Product ID
84386-010_9f75ad9f-40e7-4e6a-b722-f4c3e0be3432
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Isotretinoin
Dosage form
CAPSULE
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA220336
Marketing category
ANDA
Marketing start
2026-09-10
Substance
ISOTRETINOIN
Active strength
30 mg/1
Pharmacologic classes
Retinoid [EPC], Retinoids [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A220336-001ISOTRETINOINISOTRETINOIN20MGCAPSULE / ORALAB12026-09-10
A220336-002ISOTRETINOINISOTRETINOIN30MGCAPSULE / ORALAB12026-09-10
A220336-003ISOTRETINOINISOTRETINOIN40MGCAPSULE / ORALAB12026-09-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A220336-001AB1
A220336-002AB1
A220336-003AB1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A220336-001ISOTRETINOIN20MGCAPSULE / ORALAB12026-09-10d4dbc9d85df4…
2026-11-14 07:37:172026-10A220336-002ISOTRETINOIN30MGCAPSULE / ORALAB12026-09-10d4dbc9d85df4…
2026-11-14 07:37:172026-10A220336-003ISOTRETINOIN40MGCAPSULE / ORALAB12026-09-10d4dbc9d85df4…
2026-10-15 13:18:302026-09A220336-001ISOTRETINOIN20MGCAPSULE / ORALAB12026-09-10c2088c7a36db…
2026-10-15 13:18:302026-09A220336-002ISOTRETINOIN30MGCAPSULE / ORALAB12026-09-10c2088c7a36db…
2026-10-15 13:18:302026-09A220336-003ISOTRETINOIN40MGCAPSULE / ORALAB12026-09-10c2088c7a36db…
2026-09-14 22:38:342026-08A220336-001ISOTRETINOIN20MGCAPSULE / ORALAB12026-09-1084e616aacf4f…
2026-09-14 22:38:342026-08A220336-002ISOTRETINOIN30MGCAPSULE / ORALAB12026-09-1084e616aacf4f…
2026-09-14 22:38:342026-08A220336-003ISOTRETINOIN40MGCAPSULE / ORALAB12026-09-1084e616aacf4f…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A220336-001AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A220336-002AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A220336-003AB11d4dbc9d85df4…
2026-10-15 13:18:302026-09A220336-001AB11c2088c7a36db…
2026-10-15 13:18:302026-09A220336-002AB11c2088c7a36db…
2026-10-15 13:18:302026-09A220336-003AB11c2088c7a36db…
2026-09-14 22:38:342026-08A220336-001AB1184e616aacf4f…
2026-09-14 22:38:342026-08A220336-002AB1184e616aacf4f…
2026-09-14 22:38:342026-08A220336-003AB1184e616aacf4f…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Isotretinoin
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ISOTRETINOIN30 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
EH28UP18IFInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
197844Internal RxNorm lookup
197845Internal RxNorm lookup
403930Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
189c014a-1d66-4ba9-ae47-9ed6138ca82bAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IsotretinoinISOTRETINOINAurobindo Pharma Limited189c014a-1d66-4ba9-ae47-9ed6138ca82b2026-09-11Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 220336
application number: ANDA220336
ndc (product): 84386-010

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
84386-010-03843860010033 BLISTER PACK in 1 CARTON (84386-010-03) / 10 CAPSULE in 1 BLISTER PACK3 blister pack2026-09-10NoNoCurrent